ALPEK Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw a 50% sequential and 18% year-over-year EBITDA increase, driven by strong execution and favorable market conditions amid Middle East disruptions. Asset optimization, growth investments, and deleveraging remain priorities, with Q2 EBITDA expected to exceed $200 million.
Fiscal Year 2025
-
2025 saw a 30% drop in EBITDA due to overcapacity and weak demand, but free cash flow improved 57%. 2026 guidance projects $450–$500 million EBITDA, with deleveraging and asset sales as top priorities. Market recovery remains uncertain, but strategic growth and cost controls are in focus.
-
Sequential EBITDA and cash flow improved, but full-year guidance was revised down due to persistent oversupply, low margins, and heavy imports. Merger approval and new U.S. tariffs on PET are expected to benefit results from 2026.
-
Second quarter results showed resilient plastics and chemicals performance offsetting polyester margin pressure from global oversupply and tariffs. Guidance was revised lower, with a focus on cost control, asset optimization, and financial flexibility.
-
Faced with global overcapacity and trade uncertainties, margins declined, especially in polyester, while plastics and chemicals remained stable. Asset sales, cost controls, and new business initiatives are key to deleveraging and future growth, with working capital release expected by year-end.
Fiscal Year 2024
-
Comparable EBITDA for 2024 exceeded guidance at $699 million, driven by cost-saving initiatives and higher container freight costs. 2025 guidance anticipates lower EBITDA of $625 million due to reduced freight rates, with a focus on further cost reductions and maintaining strong cash flow.
-
Q3 2024 results exceeded expectations with strong EBITDA, driven by high freight costs and stable demand. Guidance for 2024 EBITDA was raised, CapEx reduced, and leverage is expected to improve further. The spin-off process is progressing, and cost savings initiatives are on track.
-
Second quarter results met expectations with improved cash flow, cost reductions, and stable volumes despite operational challenges. Full-year guidance is reaffirmed, deleveraging continues, and strategic investments are prioritized, with no dividends planned for 2024.